Business & Tech
New Baxter Study to Help Heart Disease Treatment
Approximately 450 people at 50 sites to participate.
Deerfield based will start a clinical research trial aimed at evaluating whether a person’s own stem cells can help the treatment of coronary artery disease, according to an article PipelineReview.Com.
“The prospect of using a person’s own adult stem cells to restore and repair blood flow in CMI is a very exciting concept based on a biological regenerative approach,” Baxter’s Chief Science and Innovation Officer Norbert Riedel said.
Approximately 450 people at 50 sites around the United States will be part of the study. Previous preclinical studies investigating these cells have shown an increase in capillary density and improved cardiac function.
